At a CAGR of 8.6% | Neuromodulation Market Worth $8.8 billion by 2025

ReportsnReports published a research report on “Neuromodulation Market” – Industry Analysis, Scope, Stake, Progress, Trends and Forecast to 2025. An exclusive data offered in this report is collected by research and industry experts team.

Get Free Sample Research Report @

The Global Neuromodulation Market size is projected to reach USD 8.8 Billion by 2025 from US$ 5.8 Billion in 2020, at a CAGR of 8.6%. This report spread across 156 Pages, Profiling 14 Companies and Supported with 177 Tables and 25 figures are now available in this research.


Top Key Players- Medtronic (Ireland), Boston Scientific Corporation (US), Abbott (US), LivaNova (UK), Synapse Biomedical, Inc. (US), Nevro Corporation (US), NeuroSigma (US), NeuroPace (US), Neuronetics (US), and BioControl Medical (Israel).


Based on Technology, the neuromodulation market is segmented into internal neuromodulation and external neuromodulation. The internal neuromodulation segment accounted for the largest market share in 2019. This segment is also expected to register the highest growth during the forecast period. This growth in this segment is driven primarily by reductions in post-surgical complications and length of hospital stay, as well as long-term cost savings associated with the use of internal neuromodulation devices.


Based on Type, the external neuromodulation market is segmented into transcutaneous electrical nerve stimulation (TENS), transcranial magnetic stimulation (TMS), and respiratory electrical stimulation (RES).TENS accounted for the largest share of the external neuromodulation market in 2019, owing to the higher incidence of chronic disorders, the wide range of applications of these devices, their cost-effectiveness, and the rising demand for non-invasive therapy.


“Asia Pacific neuromodulation market is expected to witness the highest growth during the forecast period.”

The Asia Pacific market is estimated to grow at the highest CAGR during the forecast period, primarily due to the high incidence of neurological disorders, increasing public and private investments, and ongoing research.


Ask For 25% Discount @


Table of Contents:

1 Introduction

1.1 Objectives of the Study

1.2 Market Definition

1.3 Market Scope

1.3.1 Years Considered for the Study

1.4 Currency

1.5 Limitations

1.6 Stakeholders


2 Research Methodology

2.1 Research Data

2.2 Secondary Data

2.2.1 Secondary Sources

2.3 Primary Data

2.3.1 Key Data From Primary Sources

2.4 Market Size Estimation

2.4.1 Bottom-Up Approach

2.4.2 Top-Down Approach

2.4.3 Growth Forecast

2.5 Market Breakdown and Data Triangulation

2.6 Assumptions for the Study


3 Executive Summary


4 Premium Insights

4.1 Neuromodulation: Market Overview

4.2 North America: Neuromodulation Market, By Technology (2019)

4.3 Global Spinal Cord Stimulation Market, By Application


5 Market Overview

5.1 Introduction

5.2 Market Dynamics

5.2.1 Drivers Rising Prevalence of Neurological Disorders Research Into Expanding the Applications of Neuromodulation Rising Awareness on Neurodegenerative Disorders

5.2.2 Restraints High Cost of Neuromodulation Procedures

5.2.3 Opportunities Expansion in Emerging Economies

5.2.4 Challenges Dearth of Trained Professionals

….And More


Ask Question @

Leave a Reply

Your email address will not be published. Required fields are marked *